Anila Mehta

541 citations
9 papers · 392 indexed · h-index 6
Topics
Antiplatelet Therapy and Cardiovascular Diseases (2 papers)Diabetes Treatment and Management (2 papers)Coronary Interventions and Diagnostics (2 papers)

In The Last Decade

Anila Mehta

9 papers receiving 386 citations

Peers

Anila Mehta
Comparison fields: 5 of 69
  • Oncology 168
  • Immunology 133
  • Molecular Biology 83
  • Physiology 73
  • Radiology, Nuclear Medicine and Imaging 64
Replace Lijun Xu with:
Lijun Xu China
Guocan Yang China
Emma Searle United Kingdom
Hao Ding China
B Liccardo Italy
Miranda Versloot Netherlands
Carine Chaleteix France
Eugene Tan United States
Karim Bennaceur United Kingdom
Phillip Binkley United States
Anila Mehta relative to Lijun Xu China Lijun Xu's profile →
Citations per field
00.5×1.5×2.1×
Lijun Xu · 1×
Citations per year

Countries citing papers authored by Anila Mehta

Since Specialization
Citations

This map shows the geographic impact of Anila Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anila Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anila Mehta more than expected).

Fields of papers citing papers by Anila Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anila Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anila Mehta. The network helps show where Anila Mehta may publish in the future.

Co-authorship network of co-authors of Anila Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Anila Mehta. A scholar is included among the top collaborators of Anila Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anila Mehta. Anila Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 10
2 17
3 4
4 6
5 5
6 240
7 44
8 1
9
Enzyme replacement therapy and renal function in 201 patients with Fabry disease.
65

About Anila Mehta

Anila Mehta is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 9 papers that have together received 392 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Diabetes Treatment and Management (2 papers) and Coronary Interventions and Diagnostics (2 papers). The work is most often cited by research in Immunology (133 citations), Oncology (168 citations) and Physiology (73 citations). Anila Mehta has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Taylor Kalomeris, Frank Dubois, Benjamin M. Larimer, Eric Wehrenberg-Klee, Umar Mahmood, Keith T. Flaherty, Genevieve M. Boland, Sandro Feriozzi, Gere Sunder‐Plassmann and Andreas Schwarting. Their work appears in journals such as Cancer Research, Clinical Journal of the American Society of Nephrology and Trends in Cardiovascular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026